The at-home IVD testing market is a growing market with much potential. This report, At-Home Diagnostic Testing Markets and Trends (COVID-19, FOB, Glucose, HIV and Other Tests), analyzes at-home tests where the entire process is done at home. A sample is collected, and the results are provided in under one hour. This does not include self-collection at home and then sent to a laboratory where it can be analyzed.
This report is segmented into three areas:
Glucose
Infectious disease
Other areas
The information for this report was gathered using both primary and secondary research including comprehensive research of secondary sources such as company literature, databases, investment reports, and medical and business journals.
All market data pertains to the world market at the manufacturers’ level. The market includes manufacturer tests. The base year for data was 2021. Data are provided for 2021 and 2026 with compound annual growth rates (CAGRs) for 2021 and 2026. Competitive analysis is provided for the top five participants in the market. Regional breakdowns are surveyed for United States, EMEA, Asia-Pacific and Rest of World for 2019-2021. The forecasted market analysis for 2021-2026 was largely based on demographic trends, new developments, innovative technology and global expansion.
Table of Contents
Chapter 1. Executive Summary
Industry at a Glance
Scope and Methodology
Size and Growth of the Market
Figure 1-1: Global At-Home IVD Market by Key Segment (Glucose, COVID-19, Other), 2019-2021
Key Issues and Trends Affecting the Market
Competitive Outlook
Conclusion Highlights
Chapter 2: Introduction
Overview
At-Home Tests by Test Type
Table 2-1: Global At-Home IVD Market by Test Type, 2021 ($BN)
Figure 2-1: Global At-Home IVD Market by Distribution of Sales by Segment (Glucose, COVID-19, HIV, Other Infections, Cholesterol, Drug of Abuse, Coagulation, FOB, Pregnancy & Fertility, Other), 2021
At-Home Tests by Sample Type
Table 2-2: Global At-Home IVD Market by Sample Type, 2021 ($BN)
Figure 2-2: Global At-Home IVD Market by Distribution of Sales by Sample Type (Blood, Urine, Oral/Saliva, Nasal, Stool, Other), 2019 and 2021
Blood Samples
Figure 2-3: Estimated Distribution of Blood Sample Sales by Test Type, 2021
Urine Samples
Figure 2-4: Estimated Distribution of Urine Sample Sales by Test Type, 2021
Oral/Saliva Samples
Figure 2-5: Estimated Distribution of Oral/Saliva Sample Sales by Test Type, 2021
Nasal Samples
Figure 2-6: Estimated Distribution of Nasal Sample Sales by Test Type, 2021
Stool Samples
Figure 2-7: Estimated Distribution of Stool Sample Sales by Test Type, 2021
Other
Chapter 3: Issues and Trends
COVID-19
At-Home COVID-19 Test Distribution of Sales by Vendor
Insurance for At-Home Tests
Diabetes State Mandates – State-Level Insurance Mandates for Benefits, ACA Marketplace Coverage
At-Home IVD Testing Drivers and Challenges
Chapter 4: Market Participants
Abbott
Table 4-1: Corporate Summary
Company Overview
Acon Laboratories, Inc.
Table 4-2: Acon Laboratories Corporate Summary
Company Overview
Ascensia Diabetes Care Holdings AG
Table 4-3: Ascensia Diabetes Care Corporate Summary
